Home Multimedia Podcasts NOVEL NANOCATALYST FOR PHARMACEUTICAL MANUFACTURING NOVEL NANOCATALYST FOR PHARMACEUTICAL MANUFACTURING October 1, 2009 – Inteview with Eugene Zubarev, Ph.D., Associate Professor, Department of Chemistry, Rice University /wp-content/uploads/2018/09/gc284_10_1_2009.mp3 DrugsPharmaceutical chemistryPharmacology Also of Interest Alexandria Founder Talks Takeda, Massachusetts, NYC, and 30th Anniversary Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma 89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate StockWatch: Challengers Take Aim at Lilly, Novo Nordisk Novo Nordisk Expands Boston Area Research and Early Development Related Media BIO CEO Rachel King Outlines Industry's Challenges on "Close to the Edge" Emerging Markets Collaborate to Succeed in Post-Pandemic World Global Single-Use Network Support Assurance of Supply Resins Address Downstream Purification Concerns Materials Sourcing: Precautions and Improvements for Cell and Gene Therapies Lessons from the COVID Crisis: An Interview with Peter Hotez Related Content Alexandria Founder Talks Takeda, Massachusetts, NYC, and 30th Anniversary Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma 89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate